Publication Author: Patrick_Donald
-
Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension.
Patrick D. Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. Value Health. 2013 Jun;16(4):455-6. doi: 10.1016/j.jval.2013.04.001.
rakerr2
-
Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force.
Matza LS, Patrick DL, Riley AW, Alexander JJ, Rajmil L, Pleil AM, Bullinger M. Pediatric Patient-Reported Outcome Instruments for Research to Support Medical Product Labeling: Report of the ISPOR PRO Good Research Practices for the Assessment of Children
rakerr2
-
Quality of life in youth with severe to profound sensorineural hearing loss.
Meyer A, Sie K, Skalicky A, Edwards TC, Schick B, Niparko J, Patrick DL. Quality of life in youth with severe to profound sensorineural hearing loss. JAMA Otolaryngol Head Neck Surg. 2013 Mar;139(3):294-300. doi: 10.1001/jamaoto.2013.35.
rakerr2
-
Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension.
Calvert M, Blazeby J, Altman DG, Revicki DA, Moher D, Brundage MD; CONSORT PRO Group. Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA. 2013 Feb 27;309(8):814-22. doi: 10.1001/jama.2013.879.
rakerr2
-
Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acid.
Cleeland CS, Body JJ, Stopeck A, von Moos R, Fallowfield L, Mathias SD, Patrick DL, Clemons M, Tonkin K, Masuda N, Lipton A, de Boer R, Salvagni S, Oliveira CT, Qian Y, Jiang Q, Dansey R, Braun A, Chung K. Pain outcomes in patients with advanced breast ca
rakerr2
-
GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes.
Guyatt GH, Thorlund K, Oxman AD, Walter SD, Patrick D, Furukawa TA, Johnston BC, Karanicolas P, Akl EA, Vist G, Kunz R, Brozek J, Kupper LL, Martin SL, Meerpohl JJ, Alonso-Coello P, Christensen R, Schunemann HJ. GRADE guidelines: 13. Preparing summary of
rakerr2
-
School placement and perceived quality of life in youth who are deaf or hard of hearing.
Schick B, Skalicky A, Edwards T, Kushalnagar P, Topolski T, Patrick D. School placement and perceived quality of life in youth who are deaf or hard of hearing. J Deaf Stud Deaf Educ. 2013 Jan;18(1):47-61. doi: 10.1093/deafed/ens039. Epub 2012 Nov 26.
rakerr2
-
Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acid.
Vadhan-Raj S, von Moos R, Fallowfield LJ, Patrick DL, Goldwasser F, Cleeland CS, Henry DH, Novello S, Hungria V, Qian Y, Feng A, Yeh H, Chung K. Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zole
rakerr2
-
Universal health outcome measures for older persons with multiple chronic conditions.
Working Group on Health Outcomes for Older Persons with Multiple Chronic Conditions. Universal health outcome measures for older persons with multiple chronic conditions. J Am Geriatr Soc. 2012 Dec;60(12):2333-41. doi: 10.1111/j.1532-5415.2012.04240.x. Ep
rakerr2
-
Development and validation of the self-management profile for type 2 diabetes (SMP-T2D).
Peyrot M, Bushnell DM, Best JH, Martin ML, Cameron A, Patrick DL. Development and validation of the self-management profile for type 2 diabetes (SMP-T2D). Health Qual Life Outcomes. 2012 Oct 5;10:125. doi: 10.1186/1477-7525-10-125.
rakerr2